In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Celera acquires Applied Biosystems' 50% interest in JV

Executive Summary

Applera's publicly traded divisions Celera Genomics (CG) and Applied Biosystems (AB) have decided to fold their joint venture, Celera Diagnostics (CD), which was formed in 2001 to discover and develop gene- and protein-based tests. CG has bought out AB's 50% interest for $30mm in cash.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Partial Acquisition
    • Payment Includes Cash

Related Companies